139 related articles for article (PubMed ID: 37537060)
1. A case report of SMARCA4-deficient undifferentiated tumor in the esophago-gastric junction.
Deng L; Li B
Asian J Surg; 2023 Nov; 46(11):5330-5331. PubMed ID: 37537060
[No Abstract] [Full Text] [Related]
2. SMARCA4 Mutations in Carcinomas of the Esophagus, Esophagogastric Junction, and Stomach.
Neil AJ; Zhao L; Isidro RA; Srivastava A; Cleary JM; Dong F
Mod Pathol; 2023 Jun; 36(6):100183. PubMed ID: 37054973
[TBL] [Abstract][Full Text] [Related]
3. SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction.
Horton RK; Ahadi M; Gill AJ; Said S; Chen ZE; Bakhshwin A; Nichols M; Goldblum JR; Graham RP
Am J Surg Pathol; 2021 Mar; 45(3):414-420. PubMed ID: 33027072
[TBL] [Abstract][Full Text] [Related]
4. A BAFfling liver aspirate: Metastatic high grade SMARCA4 deficient undifferentiated gastroesophageal junction carcinoma masquerading as a hematolymphoid malignancy.
Kilic AI; Mirza K; Mehrotra S; Pambuccian SE
Diagn Cytopathol; 2019 Jul; 47(7):725-732. PubMed ID: 30897306
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological characteristics of gastric SMARCA4-deficient undifferentiated/rhabdoid carcinoma].
Wu JY; Jiang K; Yan LJ; Yin LS; Huang XZ; Jia L; Sun Y
Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):447-453. PubMed ID: 37106285
[No Abstract] [Full Text] [Related]
6. The first case of SMARCA4-deficient sarcoma of stomach.
Ota T; Ishikawa T; Yasuda R; Yasuda T; Okayama T; Inoue K; Dohi O; Yoshida N; Kamada K; Uchiyama K; Takagi T; Konishi H; Naito Y; Matsuyama K; Yamaguchi T; Ootsuka K; Yoshida A; Kishimoto M; Itoh Y
Clin J Gastroenterol; 2022 Jun; 15(3):531-536. PubMed ID: 35175571
[TBL] [Abstract][Full Text] [Related]
7. Malignant undifferentiated and rhabdoid tumors of the gastroesophageal junction and esophagus with SMARCA4 loss: a case series.
Gupta S; Noona SW; Pambuccian SE; Robinson B; Martin LW; Williams E; Stelow EB; Raghavan SS
Hum Pathol; 2023 Apr; 134():56-65. PubMed ID: 36549598
[TBL] [Abstract][Full Text] [Related]
8. The clinicopathological and molecular analysis of gastric cancer with altered SMARCA4 expression.
Huang SC; Ng KF; Yeh TS; Cheng CT; Chen MC; Chao YC; Chuang HC; Liu YJ; Chen TC
Histopathology; 2020 Aug; 77(2):250-261. PubMed ID: 32343857
[TBL] [Abstract][Full Text] [Related]
9. [Thoracic
Xiong Y; Zhang B; Nie LG; Wu SK; Zhao H; Li D; DI JT
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):351-356. PubMed ID: 37042149
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma of the esophago-gastric junction.
Siewert JR; Stein HJ; Feith M
Scand J Surg; 2006; 95(4):260-9. PubMed ID: 17249275
[TBL] [Abstract][Full Text] [Related]
11. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A
Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939
[TBL] [Abstract][Full Text] [Related]
12. Carcinoma at the esophago-gastric junction--its biological behaviour toward the squamous epithelium.
Noguchi Y; Imada T; Matsumoto A
Jpn J Surg; 1989 Mar; 19(2):143-52. PubMed ID: 2724715
[TBL] [Abstract][Full Text] [Related]
13. FDG PET/CT in a Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor.
Guo J; Liao Z; Chen Q; Dong A; Huang M
Clin Nucl Med; 2023 Dec; 48(12):1111-1113. PubMed ID: 37882056
[TBL] [Abstract][Full Text] [Related]
14. An Unusual Case of Gastric Mass: SMARCA4-deficient Undifferentiated Gastric Carcinoma.
Lin JL; Wu TN; Zhang JY
J Gastrointest Surg; 2023 Sep; 27(9):2003-2005. PubMed ID: 37038038
[No Abstract] [Full Text] [Related]
15. Clinical tumor staging of adenocarcinoma of the esophagus and esophagogastric junction.
Turkington RC; Parkes E; Kennedy RD; Eatock MM; Harrison C; McCloskey P; Purcell C
J Clin Oncol; 2015 Mar; 33(9):1088. PubMed ID: 25646194
[No Abstract] [Full Text] [Related]
16. SMARCA4-deficient undifferentiated tumor: A case report.
Segado Martínez M; Ruiz García G
Med Clin (Barc); 2022 Nov; 159(9):e59-e60. PubMed ID: 35987734
[No Abstract] [Full Text] [Related]
17. Histopathologic classification of adenocarcinoma of the esophagogastric junction.
Baldus SE
Recent Results Cancer Res; 2010; 182():29-38. PubMed ID: 20676869
[No Abstract] [Full Text] [Related]
18. [Treatment of the esophago-gastric junction adenocarcinoma].
Bîrlă R; Losif C; Gîndea C; Hoară P; Constantinoiu S
Chirurgia (Bucur); 2008; 103(2):143-53. PubMed ID: 18457092
[TBL] [Abstract][Full Text] [Related]
19. Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter.
Businello G; Angerilli V; Lonardi S; Bergamo F; Valmasoni M; Farinati F; Savarino E; Spolverato G; Fassan M
Updates Surg; 2023 Feb; 75(2):291-303. PubMed ID: 35834132
[TBL] [Abstract][Full Text] [Related]
20. Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report.
Kito Y; Kawashima K; Saigo C; Hasegawa M; Nomura S; Mikamo T; Hanamatsu Y; Matsuo Y; Takeuchi T
Diagn Pathol; 2022 Feb; 17(1):29. PubMed ID: 35151345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
